GE HealthCare raises dividend per GE HealthCare stock

Published on 10/01/2026 at 15:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GE HealthCare pays USD 0.04 after a 14.00 percent increase. GE HealthCare stock costs EUR 57.88 on October 1, 2026 after EUR 57.96.

Techniker bedient MRT-Scanner in hellem Krankenhaus-Untersuchungsraum mit Flurblick — GE HealthCare US36266G1076 zeigt einen modernen MRT-Scanner im hellen klinischen Krankenhaus mit Techniker, Illustration mit AI erstellt.

GE HealthCare (ISIN US36266G1076) was trading at EUR 57.88 at Lang & Schwarz on October 1, 2026 at 3:00 p.m. CEST, down 0.14 percent versus the EUR 57.96 prior close. On September 22, 2026, GE HealthCare raised its quarterly dividend to USD 0.04 per share, a 14.00 percent increase from the previous quarter.

Dividend increase sets the tone

The dividend is payable on November 13, 2026, to shareholders of record on October 23, 2026, according to GE HealthCare. The payment is a small cash-return signal, but the 14.00 percent increase gives the latest corporate announcement a concrete shareholder angle.

The broader operating picture is mixed. GE HealthCare's Patient Care Solutions division remained challenged in the second quarter of 2026, while management continued a strategic review of that business, according to the company's July 29, 2026 results release.

Orders grew faster than revenue

In the second quarter of 2026, revenue reached USD 5.3 billion, up 5.70 percent year over year, while organic revenue growth was 3.50 percent. Organic orders grew 11.10 percent, compared with 3.40 percent in the year-ago period, and backlog reached USD 23.9 billion, according to GE HealthCare.

Adjusted earnings per share rose to USD 1.13 from USD 1.06 in the second quarter of 2025, while adjusted EBIT margin slipped to 14.20 percent from 14.60 percent. The contrast matters: demand indicators improved, but profitability still reflects pressure from Patient Care Solutions, memory chips, oil and freight costs.

For full-year 2026, GE HealthCare reaffirmed organic revenue growth guidance of 3.00 percent to 4.00 percent and adjusted earnings per share guidance of USD 4.80 to USD 5.00. The company also expects free cash flow of USD 1.6 billion, with the outlook including an estimated USD 250 million of inflation-related costs.

Needham sees valuation upside

Needham initiated coverage with a Buy rating and a USD 93.00 price target on September 22, 2026, as CNBC reported. The firm expects mid-single-digit revenue growth and high-single-digit earnings-per-share growth over the next year, while its base case assumes a 17-times multiple on 2027 earnings.

GE HealthCare stock stays under pressure

On Nasdaq, GEHC was last at USD 65.37 on September 30, 2026, compared with a 52-week range of USD 58.75 to USD 89.77. The USD 29.5 billion market capitalization and the position 27.18 percent below the 52-week high show why the dividend announcement and the operating recovery are being assessed together.

GE HealthCare stock was trading at EUR 57.88 at Lang & Schwarz on October 1, 2026 at 3:00 p.m. CEST, down 0.14 percent versus the EUR 57.96 prior close. The neutral daily move leaves the quarterly dividend, order growth and margin path as the clearest measurable reference points for the next report.